Home › Funds › Winning Points Advisors, LLC › ABT

Winning Points Advisors, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Winning Points Advisors, LLC reported holding 6,691 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$607K, representing 0.80% of its reported portfolio and ranking #23 among its reported holdings. Winning Points Advisors, LLC has disclosed ABT holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)6.69K sh
Reported value held$607.14K
Portfolio Weight0.80%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Winning Points Advisors, LLC's ABT position evolved

Winning Points Advisors, LLC first disclosed a stake in ABT in Q3 2024 at 7,100 shares (US$697K). The position peaked in Q4 2025 at 7,370 shares, worth US$923K. Across 4 filings, Winning Points Advisors, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 6,691 shares valued at US$607K.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 7.10K $696.65K New
Q4 2025 7.37K $923.00K Add
Q1 2026 6.69K $686.97K Reduce
Q2 2026 6.69K $607.14K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Winning Points Advisors, LLC held ABT?

Winning Points Advisors, LLC has disclosed ABT holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

What is Winning Points Advisors, LLC's current position in ABT?

As of Q2 2026, Winning Points Advisors, LLC holds 6.69K shares of ABT (ABBOTT LABORATORIES), valued at $607.14K, representing 0.80% of its reported portfolio and ranking #23.

Has Winning Points Advisors, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), Winning Points Advisors, LLC held unchanged its position in ABT. The position peaked in Q4 2025 at 7.37K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.